Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Icosavax, Inc. (ICVX)

7.42   0.14 (1.92%) 08-18 07:58
Open: 7.06 Pre. Close: 7.28
High: 7.46 Low: 6.91
Volume: 249,205 Market Cap: 296(M)
Icosavax, Inc., a biopharmaceutical company, develops vaccines against infectious diseases. The company, with the help of its virus-like particle (VLP) platform technology, focuses primarily on life-threatening respiratory diseases. Its products in pipeline include IVX-121, a vaccine candidate with RSV target and is under Phase 1/1b clinical trial; IVX-A12, a respiratory syncytial virus (RSV) monovalent antigen candidate with RSV/human metapneumovirus (hMPV) bivalent target indication; IVX-241, a vaccine candidate with hMPV target; and IVX-411, an original receptor binding domain (RBD) sequence antigen with SARS-CoV-2 target indication and is under Phase 1/2 clinical trial. The company was incorporated in 2017 and is headquartered in Seattle, Washington.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 7.47 - 7.5 7.5 - 7.52
Low: 6.83 - 6.87 6.87 - 6.9
Close: 7.36 - 7.42 7.42 - 7.47

Technical analysis

as of: 2022-08-17 4:24:11 PM
Overall:       
Stoxline posted a SELL today, upgraded from strong sell. Downward movement continues, but could change at any time.
Target: Six months: 9.7     One year: 11.1
Support: Support1: 6.36    Support2: 5.29
Resistance: Resistance1: 8.31    Resistance2: 9.51
Pivot: 7.86
Moving Average: MA(5): 8.26     MA(20): 7.81
MA(100): 7.81     MA(250): 17.17
MACD: MACD(12,26): 0.1     Signal(9): 0.1
Stochastic oscillator: %K(14,3): 50.9     %D(3): 65.9
RSI: RSI(14): 46.3
52-week: High: 41.97  Low: 4
Average Vol(K): 3-Month: 225 (K)  10-Days: 106 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
[ ICVX ] has closed above bottom band by 36.4%. Bollinger Bands are 31.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Thu, 18 Aug 2022
Jefferies Financial Group Research Analysts Lower Earnings Estimates for Icosavax, Inc. (NASDAQ:ICVX) - MarketBeat

Thu, 18 Aug 2022
Contrasting Tarsus Pharmaceuticals (NASDAQ:TARS) & Icosavax (NASDAQ:ICVX) - Defense World

Tue, 16 Aug 2022
Health Care Sector Update for 08/16/2022: ICVX,GNPX,ACLX - Nasdaq

Mon, 15 Aug 2022
2022-08-15 | NDAQ:ICVX | Press Release | Icosavax Inc. - Stockhouse

Fri, 29 Jul 2022
Having purchased US$720k worth of Icosavax, Inc. (NASDAQ:ICVX) stock, the recent 11% pullback is not what insiders may have expected - Simply Wall St

Fri, 29 Jul 2022
Icosavax discovers what caused its lead vaccine to flop, and doesn't see it affecting follow-up programs - Endpoints News

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. 0 (M)
Shares Float 40 (M)
% Held by Insiders 2.127e+007 (%)
% Held by Institutions 12.9 (%)
Shares Short 930 (K)
Shares Short P.Month 0 (K)

Stock Financials

EPS -6.375e+007
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin (%) 0
Operating Margin (%) -1
Return on Assets (ttm) 0.6
Return on Equity (ttm) -19.9
Qtrly Rev. Growth 6.38e+006
Gross Profit (p.s.) -0.8
Sales Per Share 0.19
EBITDA (p.s.) -1.15
Qtrly Earnings Growth -3.2
Operating Cash Flow 0 (M)
Levered Free Cash Flow -52 (M)

Stock Valuations

PE Ratio -0.01
PEG Ratio 0
Price to Book value 0
Price to Sales 37.13
Price to Cash Flow 0

Stock Dividends

Dividend 0
Forward Dividend 821880
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
StockChart iOS
stoxline_lite
StoxlineLite iOS
stoxline_pro
StoxlineLite iOS
Option_Calculator
OptionCalc iOS
android_stock_chart
StockChart Android
stoxline_lite
StoxlineLite Android
stoxline_pro
StoxlinePro Android
Option_Calculator
OptionCalc Android
(c) 2006-2022 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.